Mice with xenografts of HCT116 p53 +/+ and HCT p53 −/− exhibited a significantly lower tumour volume and luciferase activity in response to the combined treatment (p<0.005) (Figure 8A and 8B). The gene discussed is TP53; the disease is neoplasm.